Immune Non-Responders - A Remaining Unmet Need | Satellite Symposium at EACS 2021

Welcome

Despite remarkable improvements in antiretroviral therapy (ART), immune reconstitution remains limited in some patients even a long time after ART initiation and impacts their life expectancy. This is of particular concern for young people that acquire HIV perinatally, or early in their life. While early ART initiation holds promise to improve immune capacity, late presenters, and underdiagnosis remain of considerable concern. Cellular and molecular mechanisms underlying HIV-associated immune activation and inflammation remain extensively studied, as well as adequate biomarkers to monitor ART-induced repair of damaged tissue. This program aims at bringing together basic, translational, and clinical researchers to disseminate the latest knowledge in this area, and fuel discussion on the many remaining unknowns to catalyze future research.

Program Director

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center Tel Aviv, Israel

General Information

COVID-19 Update

Responding to the changing COVID-19 situation, the Managing HIV Patients with Limited Treatment Options will be held as a hybrid meeting. The meeting will be held in London, United Kingdom, and also offers the opportunity to participate virtually.

By merging in-person communication and virtual elements, the hybrid meeting format is an optimal solution in light of the current circumstances. The Conference Organizers will continue to observe the ongoing COVID-19 pandemic and will take necessary steps to ensure that the meeting will be held in compliance with relevant regulations, prioritizing the health and safety of our participants.

We are available to answer any questions or concerns that you may have about your participation at the Managing HIV Patients with Limited Treatment Options. For more information, please contact Goda Adomonis at goda.adomonis@amededu.com.

To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.

Learning Objectives

After participating at this educational activity, participants will be able to:

- Understand challenges of poor immune reconstitution and potential therapeutic interventions
- Comprehend CD4 response in recent studies, including inflammatory markers, and importance of gp120 inhibition
- Increase knowledge on molecular and cellular mechanisms of ART-associated immune reconstitution

Certificate of Attendance

A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.

Conference Materials

Conference materials can be obtained upon registration at meeting room on the meeting day. An official program and speakers' bios will be sent by e-mail to our virtual attendees one day prior to the meeting.

Disclaimer

This program is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.

Language

The official language of the meeting is English

Liability and Insurance

By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Payment and Procedure of Online Registration

The registration fee is waived for all healthcare professionals.

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Venue

TBC